Innovative MedTech Inc.
IMTH · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $1 | $0 |
| % Growth | 5.8% | 32.9% | 271.8% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $2 | $2 | $1 | $0 |
| % Margin | 96.4% | 96.7% | 94.6% | 97.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6 | $2 | $20 | $1 |
| SG&A Expenses | $6 | $2 | $20 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$0 | $3 | $0 | -$0 |
| Operating Expenses | $6 | $5 | $20 | $1 |
| Operating Income | -$4 | -$4 | -$18 | -$1 |
| % Margin | -234.2% | -210.1% | -1,406.6% | -203.1% |
| Other Income/Exp. Net | -$4 | -$0 | $0 | -$3 |
| Pre-Tax Income | -$8 | -$4 | -$18 | -$3 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$8 | -$4 | -$18 | -$3 |
| % Margin | -435% | -211.5% | -1,391.2% | -935.1% |
| EPS | -0.33 | -0.17 | -1.09 | -1.54 |
| % Growth | -94.1% | 84.4% | 29.2% | – |
| EPS Diluted | -0.33 | -0.17 | -1.09 | -1.54 |
| Weighted Avg Shares Out | 24 | 21 | 17 | 2 |
| Weighted Avg Shares Out Dil | 24 | 21 | 17 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$3 | -$18 | -$3 |
| % Margin | -420.7% | -195.3% | -1,371.1% | -883% |